The mitochondrial permeability transition in neurologic disease
暂无分享,去创建一个
[1] A. Marmarou,et al. The protective effect of cyclosporin A upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury. , 2004, Journal of neurotrauma.
[2] S. Hersch,et al. The Cellular and Subcellular Localization of Huntingtin-Associated Protein 1 (HAP1): Comparison with Huntingtin in Rat and Human , 1998, The Journal of Neuroscience.
[3] S. Orrenius,et al. Calcineurin and mitochondrial function in glutamate‐induced neuronal cell death , 1996, FEBS letters.
[4] M. Beal,et al. Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity , 1998, Experimental Neurology.
[5] I. Reynolds,et al. Ca2+‐induced permeabilization promotes free radical release from rat brain mitochondria with partially inhibited complex I , 2005, Journal of neurochemistry.
[6] T. Wallimann,et al. Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain. , 1996, Biochimica et biophysica acta.
[7] Dong-Kug Choi,et al. Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease , 2002, The Journal of Neuroscience.
[8] M. Zoratti,et al. The mitochondrial permeability transition pore may comprise VDAC molecules , 1993, FEBS letters.
[9] A. Pérez-Bouza,et al. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue , 2005, Neuroscience.
[10] B. Winblad,et al. Nicastrin, Presenilin, APH-1, and PEN-2 Form Active γ-Secretase Complexes in Mitochondria* , 2004, Journal of Biological Chemistry.
[11] Protein oxidation and age-dependent alterations in calcium homeostasis. , 2000 .
[12] R. Raghupathi,et al. Cell Death Mechanisms Following Traumatic Brain Injury , 2004, Brain pathology.
[13] M. MacDonald,et al. Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway. , 2004, Human molecular genetics.
[14] Stuart L. Schreiber,et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.
[15] S. Snyder,et al. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization , 1999, Nature Medicine.
[16] M. Murányi,et al. Bongkrekic acid ameliorates ischemic neuronal death in the cortex by preventing cytochrome c release and inhibiting astrocyte activation , 2005, Neuroscience Letters.
[17] R. Haworth,et al. The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site. , 1979, Archives of biochemistry and biophysics.
[18] B. Antonsson,et al. Activation of calcium‐independent phospholipase A2 (iPLA2) in brain mitochondria and release of apoptogenic factors by BAX and truncated BID , 2005, Journal of neurochemistry.
[19] M. Crompton,et al. Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. , 1988, The Biochemical journal.
[20] A. Halestrap,et al. Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. , 1998, The Biochemical journal.
[21] Ole A. Andreassen,et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis , 1999, Nature Medicine.
[22] B. Siesjö,et al. Acidosis promotes the permeability transition in energized mitochondria: implications for reperfusion injury. , 2001, Journal of neurotrauma.
[23] Michael Aschner,et al. Manganese Uptake and Efflux in Cultured Rat Astrocytes , 1992, Journal of neurochemistry.
[24] A. Hansen,et al. Extracellular ion concentrations during spreading depression and ischemia in the rat brain cortex. , 1981, Acta physiologica Scandinavica.
[25] P. Mecocci,et al. Oxidative damage to mitochondrial DNA shows marked age‐dependent increases in human brain , 1993, Annals of neurology.
[26] F. Menzies,et al. Mitochondrial involvement in amyotrophic lateral sclerosis , 2002, Neurochemistry International.
[27] O. Hansson,et al. Cyclosporin A and Bcl-2 do not inhibit quinolinic acid-induced striatal excitotoxicity in rodents , 2003, Experimental Neurology.
[28] H. Kimelberg,et al. Neuroprotective activity of tamoxifen in permanent focal ischemia. , 2003, Journal of neurosurgery.
[29] M. Norenberg,et al. Differential response of glutamine in cultured neurons and astrocytes , 2005, Journal of neuroscience research.
[30] F. Plum,et al. Biochemistry and physiology of brain ammonia. , 1987, Physiological reviews.
[31] M. Beal,et al. Clinically Approved Heterocyclics Act on a Mitochondrial Target and Reduce Stroke-induced Pathology , 2004, The Journal of experimental medicine.
[32] T. Hurd,et al. Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology , 2005, Biochemistry (Moscow).
[33] Ole A. Andreassen,et al. Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease , 2000, The Journal of Neuroscience.
[34] T. Hökfelt,et al. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] I. Kopin,et al. Features of the Dopaminergic Neurotoxin MPTP , 1992, Annals of the New York Academy of Sciences.
[36] M. Norenberg. A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder. , 1977, Laboratory investigation; a journal of technical methods and pathology.
[37] F. Joó,et al. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophc lateral sclerosis , 1996, Annals of neurology.
[38] W. Nicklas,et al. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.
[39] M. Crompton,et al. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. , 1998, European journal of biochemistry.
[40] Zuoshang Xu,et al. Mutant Cu, Zn Superoxide Dismutase that Causes Motoneuron Degeneration Is Present in Mitochondria in the CNS , 2002, The Journal of Neuroscience.
[41] M. Mattson,et al. Increased Sensitivity to Mitochondrial Toxin-Induced Apoptosis in Neural Cells Expressing Mutant Presenilin-1 Is Linked to Perturbed Calcium Homeostasis and Enhanced Oxyradical Production , 1998, The Journal of Neuroscience.
[42] M. Duchen. Roles of mitochondria in health and disease. , 2004, Diabetes.
[43] M. Beal,et al. Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity , 2005, Neurobiology of Disease.
[44] A. Nunomura,et al. Oxidative damage in Alzheimer’s disease: the metabolic dimension , 2000, International Journal of Developmental Neuroscience.
[45] G Fiskum,et al. Mitochondria in Neurodegeneration: Acute Ischemia and Chronic Neurodegenerative Diseases , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[46] C. Rodrigues,et al. Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. , 2001, Biochemical and biophysical research communications.
[47] W. Craigen,et al. Properties of the permeability transition in VDAC1(-/-) mitochondria. , 2006, Biochimica et biophysica acta.
[48] M. Beal. Huntington's disease, energy, and excitotoxicity , 1994, Neurobiology of Aging.
[49] A. Halestrap. Calcium, mitochondria and reperfusion injury: a pore way to die. , 2006, Biochemical Society transactions.
[50] D. Okonkwo,et al. The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury. , 2001, Journal of neurotrauma.
[51] A. F. Schinder,et al. Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity , 1996, The Journal of Neuroscience.
[52] D. Brdiczka,et al. Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. , 1998, Biochimica et biophysica acta.
[53] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[54] M. Zoratti,et al. Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. , 1992, The Journal of biological chemistry.
[55] Y. Akao,et al. Mitochondrial permeability transition mediates apoptosis induced by N‐methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl‐2 and rasagiline, N‐propargyl‐1(R)‐aminoindan , 2002, Journal of neurochemistry.
[56] A. Halestrap,et al. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. , 1990, The Biochemical journal.
[57] Y. Hatefi. The mitochondrial electron transport and oxidative phosphorylation system. , 1985, Annual review of biochemistry.
[58] J. Holstege,et al. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations , 2001, Acta Neuropathologica.
[59] A Wennberg,et al. Preclinical neurophysiological signs of parkinsonism in occupational manganese exposure. , 1992, Neurotoxicology.
[60] D. Green,et al. The Pathophysiology of Mitochondrial Cell Death , 2004, Science.
[61] F. Poccia,et al. Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH‐SY5Y cells , 1997, FEBS letters.
[62] M. Norenberg,et al. Glutamine‐induced free radical production in cultured astrocytes , 2004, Glia.
[63] James R. Burke,et al. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines , 2002, Nature Neuroscience.
[64] C. Dixon,et al. Molecular mechanisms in the pathogenesis of traumatic brain injury. , 2002, Histology and histopathology.
[65] W. Burke,et al. Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. , 2001, Free radical biology & medicine.
[66] T. Wallimann,et al. The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition , 1998, BioFactors.
[67] A. Toninello,et al. On the relationship between calcium and phosphate transport, transmembrane potential and acetoacetate-induced oxidation of pyridine nucleotides in rat-liver mitochondria. , 2005, European journal of biochemistry.
[68] J C Reed,et al. Mitochondria and apoptosis. , 1998, Science.
[69] M. Norenberg,et al. Induction of the mitochondrial permeability transition in cultured astrocytes by glutamine , 2003, Neurochemistry International.
[70] T. Wieloch,et al. Mitochondrial permeability transition in acute neurodegeneration. , 2002, Biochimie.
[71] M. Beal,et al. Bioenergetic approaches for neuroprotection in Parkinson's disease , 2003, Annals of neurology.
[72] Jeffrey D. Rothstein,et al. From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.
[73] A. Halestrap,et al. Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin. , 1991, The Biochemical journal.
[74] S. Scheff,et al. Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. , 1999, Journal of neurotrauma.
[75] J. Zuo,et al. Glucose deprivation induces mitochondrial dysfunction and oxidative stress in PC12 cell line , 2003, Journal of cellular and molecular medicine.
[76] M. Beal,et al. Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice* , 2002, The Journal of Biological Chemistry.
[77] G. Miotto,et al. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. , 1999, Biophysical journal.
[78] P. Leigh,et al. Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[79] S. Snyder,et al. p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease , 2005, Neuron.
[80] J. Coyle,et al. Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.
[81] J. Cooper,et al. Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins , 1998, Brain Research.
[82] J. Parks,et al. Neurotoxic Aβ peptides increase oxidative stress in vivo through NMDA‐receptor and nitric‐oxide‐synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro , 2001, Journal of neurochemistry.
[83] S. Korsmeyer,et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[84] M. Goldberg,et al. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[85] C. Behl. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches , 1999, Progress in Neurobiology.
[86] K. Gunter,et al. Uptake of Calcium by Mitochondria: Transport and Possible Function , 2001, IUBMB life.
[87] H. Tedeschi. THE MITOCHONDRIAL MEMBRANE POTENTIAL , 1980, Biological reviews of the Cambridge Philosophical Society.
[88] T. Sherer,et al. The rotenone model of Parkinson's disease: genes, environment and mitochondria. , 2003, Parkinsonism & related disorders.
[89] K. Csiszȧr,et al. Intrathecal cyclosporin prolongs survival of late-stage ALS mice , 2001, Brain Research.
[90] M. Mather,et al. Aging Enhances the Activation of the Permeability Transition Pore in Mitochondria , 2000, Biochemical and biophysical research communications.
[91] M. Beal,et al. Bioenergetics in Huntington's Disease , 1999, Annals of the New York Academy of Sciences.
[92] Jeffrey Robbins,et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death , 2005, Nature.
[93] D. Okonkwo,et al. Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury. , 1999, Journal of neurotrauma.
[94] D. Okonkwo,et al. Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. , 1999, Neuroreport.
[95] J M Dubinsky,et al. Calcium‐induced activation of the mitochondrial permeability transition in hippocampal neurons , 1998, Journal of neuroscience research.
[96] M. Gomez-Lazaro,et al. Malonate induces cell death via mitochondrial potential collapse and delayed swelling through an ROS‐dependent pathway , 2005, British journal of pharmacology.
[97] R. Butterworth,et al. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy. , 1993, Metabolism: clinical and experimental.
[98] M. Beal,et al. Oxidative Stress in Huntington's Disease , 1999, Brain pathology.
[99] T. Wallimann,et al. Reconstituted adenine nucleotide translocase forms a channel for small molecules comparable to the mitochondrial permeability transition pore , 1998, FEBS letters.
[100] M. Duchen,et al. β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase , 2004, The Journal of Neuroscience.
[101] J. Parks,et al. The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. , 1999, Biochimica et biophysica acta.
[102] Jason P. Sheehan,et al. Calcium Homeostasis and Reactive Oxygen Species Production in Cells Transformed by Mitochondria from Individuals with Sporadic Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[103] T. Wieloch,et al. Blockade of the Mitochondrial Permeability Transition Pore Diminishes Infarct Size in the Rat after Transient Middle Cerebral Artery Occlusion , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[104] B. Siesjö,et al. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. (1992). , 2008, Journal of neurosurgery.
[105] J. Connor,et al. Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.
[106] S. Snyder,et al. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[107] Claire-Anne Gutekunst,et al. A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration , 1999, Neuron.
[108] Whetsell Wo,et al. Neuroexcitation, excitotoxicity and human neurological disease , 1993 .
[109] J. Simard,et al. Suppression of ammonia‐induced astrocyte swelling by cyclosporin A , 2003, Journal of neuroscience research.
[110] A. Halestrap,et al. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury , 1997 .
[111] Lihua He,et al. Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function? , 2002, FEBS letters.
[112] M. Crompton. On the involvement of mitochondrial intermembrane junctional complexes in apoptosis. , 2003, Current medicinal chemistry.
[113] M. Zoratti,et al. The mitochondrial permeability transition. , 1995, Biochimica et biophysica acta.
[114] P. Schauwecker,et al. Protection Provided by Cyclosporin A against Excitotoxic Neuronal Death Is Genotype Dependent , 2003, Epilepsia.
[115] J. Kong,et al. Mitochondrial Degeneration in Amyotrophic Lateral Sclerosis , 2004, Journal of bioenergetics and biomembranes.
[116] M. Norenberg,et al. Oxidative Stress and Mitogen-Activated Protein Kinase Phosphorylation Mediate Ammonia-Induced Cell Swelling and Glutamate Uptake Inhibition in Cultured Astrocytes , 2006, The Journal of Neuroscience.
[117] M. Rice,et al. Brain edema induced by in vitro ischemia: causal factors and neuroprotection , 2003, Journal of neurochemistry.
[118] Xiaodong Wang,et al. Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.
[119] Alexander Sasha Rabchevsky,et al. Intrinsic differences in brain and spinal cord mitochondria: Implication for therapeutic interventions , 2004, The Journal of comparative neurology.
[120] B. Siesjö. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. , 1992, Journal of neurosurgery.
[121] M. Crompton,et al. Mitochondrial intermembrane junctional complexes and their involvement in cell death. , 2002, Biochimie.
[122] K. Csiszȧr,et al. Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis. , 2004, Journal of neurosurgery.
[123] A E Vercesi,et al. Mitochondrial permeability transition and oxidative stress , 2001, FEBS letters.
[124] J. Dubinsky,et al. On the mechanisms of neuroprotection by creatine and phosphocreatine , 2001, Journal of neurochemistry.
[125] W. Strittmatter,et al. In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease. , 2003, Archives of biochemistry and biophysics.
[126] G. Sobue,et al. Mitochondrial Localization of Mutant Superoxide Dismutase 1 Triggers Caspase-dependent Cell Death in a Cellular Model of Familial Amyotrophic Lateral Sclerosis* , 2002, The Journal of Biological Chemistry.
[127] M. Beal,et al. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase , 2004, Neurobiology of Disease.
[128] M. Beal,et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.
[129] P. Puttfarcken,et al. Inhibition of Age-Induced β-Amyloid Neurotoxicity in Rat Hippocampal Cells , 1996, Experimental Neurology.
[130] B. Hyman,et al. Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate , 1993, Journal of neurochemistry.
[131] P. Bernardi,et al. Properties of the Permeability Transition Pore in Mitochondria Devoid of Cyclophilin D* , 2005, Journal of Biological Chemistry.
[132] A. Lang,et al. Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.
[133] D. Nicholls. Mitochondria and calcium signaling. , 2005, Cell calcium.
[134] A. Nieminen. Apoptosis and necrosis in health and disease: role of mitochondria. , 2003, International review of cytology.
[135] W. Schubert,et al. Mitochondrial ultrastructure in Reye's syndrome (encephalopathy and fatty degeneration of the viscera). , 1971, The New England journal of medicine.
[136] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[137] B. Siesjö. Acid-base homeostasis in the brain: physiology, chemistry, and neurochemical pathology. , 1985, Progress in brain research.
[138] S. Hersch,et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease , 2000, Nature Medicine.
[139] A. Halestrap,et al. Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. , 1999, American journal of physiology. Heart and circulatory physiology.
[140] Betty Y. S. Kim,et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice , 2002, Nature.
[141] M. MacDonald,et al. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. , 2004, Human molecular genetics.
[142] P. Moreira,et al. Effect of amyloid β‐peptide on permeability transition pore: A comparative study , 2002 .
[143] C. Oliveira,et al. Mitochondrial function impairment induced by amyloid β‐peptide on PC12 cells , 1998 .
[144] P. Moreira,et al. Brain mitochondrial injury induced by oxidative stress-related events is prevented by tamoxifen , 2005, Neuropharmacology.
[145] D. Selkoe,et al. Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein , 2000, Annals of the New York Academy of Sciences.
[146] O. Andreassen,et al. Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease , 2001, Neurobiology of Disease.
[147] J. Lemasters,et al. The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury. , 1996, The Journal of pharmacology and experimental therapeutics.
[148] C. Brenner,et al. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. , 2003, Current medicinal chemistry.
[149] T. Kristian. Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage. , 2004, Cell calcium.
[150] Tetsuya Watanabe,et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death , 2005, Nature.
[151] R. Auer,et al. Biological differences between ischemia, hypoglycemia, and epilepsy , 1988, Annals of neurology.
[152] Zuoshang Xu,et al. ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes , 2003, BMC Neuroscience.
[153] M. Norenberg,et al. Manganese Induces the Mitochondrial Permeability Transition in Cultured Astrocytes* , 2004, Journal of Biological Chemistry.
[154] I. Sayeed,et al. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti‐apoptotic effects of melatonin , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[155] B. Siesjö,et al. Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat , 2001, Brain Research.
[156] D. Bonthron,et al. Platelet-derived growth factor A-chain gene transcription is mediated by positive and negative regulatory regions in the promoter. , 1994, The Biochemical journal.
[157] K. Weissenborn,et al. Neurology and the liver , 1997, Journal of neurology, neurosurgery, and psychiatry.
[158] Dean P. Jones,et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore , 2004, Nature.
[159] Bruce R. Rosen,et al. Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease , 1998, The Journal of Neuroscience.
[160] M. Norenberg,et al. Fine structural localization of glutamine synthetase in astrocytes of rat brain , 1979, Brain Research.
[161] M. Norenberg,et al. Ammonia Neurotoxicity: Role of the Mitochondrial Permeability Transition , 2003, Metabolic Brain Disease.
[162] I. Fridovich,et al. Subcellular Distribution of Superoxide Dismutases (SOD) in Rat Liver , 2001, The Journal of Biological Chemistry.
[163] M. Norenberg,et al. Oxidative Stress in the Pathogenesis of Hepatic Encephalopathy , 2004, Metabolic Brain Disease.
[164] M. Norenberg. Astroglial Dysfunction in Hepatic Encephalopathy , 1998, Metabolic Brain Disease.
[165] J. Kaiser. Manganese: A High-Octane Dispute , 2003, Science.
[166] F. Ichas,et al. A Ubiquinone-binding Site Regulates the Mitochondrial Permeability Transition Pore* , 1998, The Journal of Biological Chemistry.
[167] O. Andreassen,et al. Malonate and 3‐Nitropropionic Acid Neurotoxicity Are Reduced in Transgenic Mice Expressing a Caspase‐1 Dominant‐Negative Mutant , 2000, Journal of neurochemistry.
[168] C. Rose,et al. Acute Insult of Ammonia Leads to Calcium-dependent Glutamate Release from Cultured Astrocytes, an Effect of pH* , 2005, Journal of Biological Chemistry.
[169] M. Mattson,et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[170] M. Norenberg,et al. Ammonia‐induced production of free radicals in primary cultures of rat astrocytes , 2001, Journal of neuroscience research.
[171] J. Baldassare,et al. Molecular aspects of Huntington's disease , 1998, Journal of neuroscience research.
[172] S. Budd,et al. Mitochondria and neuronal survival. , 2000, Physiological reviews.
[173] A. Koretsky,et al. The role of creatine kinase in inhibition of mitochondrial permeability transition , 1997, FEBS letters.
[174] S. Scheff,et al. Cyclosporin A Attenuates Acute Mitochondrial Dysfunction Following Traumatic Brain Injury , 1999, Experimental Neurology.
[175] A. Hazell,et al. Hepatic Encephalopathy: An Update of Pathophysiologic Mechanisms (44433A) , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[176] A. Lehninger,et al. Regulation of Ca2+ release from mitochondria by the oxidation-reduction state of pyridine nucleotides. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[177] David Blum,et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease , 2001, Progress in Neurobiology.
[178] A. Halestrap,et al. Oxidative Stress, Thiol Reagents, and Membrane Potential Modulate the Mitochondrial Permeability Transition by Affecting Nucleotide Binding to the Adenine Nucleotide Translocase* , 1997, The Journal of Biological Chemistry.
[179] S. Maruyama,et al. Ultrastructure of swollen proximal axons of anterior horn neurons in motor neuron disease , 1990, Journal of the Neurological Sciences.
[180] R. Ramsay,et al. Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. New vistas. , 1993, Advances in neurology.
[181] Guido Kroemer,et al. Mitochondrial control of cell death , 2000, Nature Medicine.
[182] D. Borchelt,et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.
[183] N. A. Solovyova,et al. Impairment of respiratory functions in mitochondria of rats with an inherited hyperproduction of free radicals. , 1994, Biochemical and biophysical research communications.
[184] B. Siesjö,et al. Cerebral Extracellular Calcium Activity in Severe Hypoglycemia: Relation to Extracellular Potassium and Energy State , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[185] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[186] J. Quinn,et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.
[187] M. Norenberg,et al. Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes , 2001, Journal of neuroscience research.
[188] T. Koike,et al. Early apoptotic and late necrotic components associated with altered Ca2+ homeostasis in a peptide‐delivery model of polyglutamine‐induced neuronal death , 2005, Journal of neuroscience research.
[189] I. Reynolds,et al. Mitochondrial Depolarization in Glutamate-Stimulated Neurons: An Early Signal Specific to Excitotoxin Exposure , 1996, The Journal of Neuroscience.
[190] Patrizia Mecocci,et al. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.
[191] S. Paul,et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[192] M. Murphy,et al. Exposure to the parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP+) and nitric oxide simultaneously causes cyclosporin A-sensitive mitochondrial calcium efflux and depolarisation. , 1996, Biochemical pharmacology.
[193] M. Beal,et al. Excitotoxicity and nitric oxide in parkinson's disease pathogenesis , 1998, Annals of neurology.
[194] V. Shoshan-Barmatz,et al. The voltage-dependent anion channel , 2007, Cell Biochemistry and Biophysics.
[195] S. Snyder,et al. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[196] Yangzheng Feng,et al. Treatment with tamoxifen reduces hypoxic-ischemic brain injury in neonatal rats. , 2004, European journal of pharmacology.
[197] K. Beyreuther,et al. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. , 1992, The Journal of biological chemistry.
[198] F. Checler. Presenilins: structural aspects and posttranslational events. , 1999, Molecular neurobiology.
[199] D. Ganger,et al. Electron microscopic evaluation of brain edema in rabbits with galactosamine‐induced fulminant hepatic failure: Ultrastructure and integrity of the blood‐brain barrier , 1987, Hepatology.
[200] M. Mattson,et al. Pivotal Role of Mitochondrial Calcium Uptake in Neural Cell Apoptosis and Necrosis , 1999, Journal of neurochemistry.
[201] D. Choi. Excitotoxic cell death. , 1992, Journal of neurobiology.
[202] R. Rosenthal,et al. Mechanisms of Ischemic Neuroprotection by Acetyl‐l‐carnitine , 2005, Annals of the New York Academy of Sciences.
[203] M. Norenberg,et al. Mechanisms of Ammonia-Induced Astrocyte Swelling , 2005, Metabolic Brain Disease.
[204] L. Raymond,et al. Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease , 2004, Molecular and Cellular Neuroscience.
[205] D. Cassarino,et al. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration , 1999, Brain Research Reviews.
[206] T. Wieloch,et al. Cyclosporin A, But Not FK 506, Protects Mitochondria and Neurons against Hypoglycemic Damage and Implicates the Mitochondrial Permeability Transition in Cell Death , 1998, The Journal of Neuroscience.
[207] J. Julien,et al. Amyotrophic Lateral Sclerosis Unfolding the Toxicity of the Misfolded , 2001, Cell.
[208] L. Dugan,et al. The Mitochondrial Permeability Transition Pore and Nitric Oxide Synthase Mediate Early Mitochondrial Depolarization in Astrocytes during Oxygen–Glucose Deprivation , 2001, The Journal of Neuroscience.
[209] M. Norenberg,et al. Glutamine: A Trojan horse in ammonia neurotoxicity , 2006, Hepatology.
[210] M. Klingenberg,et al. Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. , 1996, Biochemistry.
[211] T. Wieloch,et al. Cyclosporin A and its nonimmunosuppressive analogue N‐Me‐Val‐4‐cyclosporin A mitigate glucose/oxygen deprivation‐induced damage to rat cultured hippocampal neurons , 1999, The European journal of neuroscience.
[212] R. Jemmerson,et al. Cytochrome C release from CNS mitochondria and potential for clinical intervention in apoptosis-mediated CNS diseases. , 2005, Antioxidants & redox signaling.
[213] J. Satrústegui,et al. Cyclosporin A targets involved in protection against glutamate excitotoxicity. , 2000, European journal of pharmacology.
[214] A. Halestrap,et al. Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. , 1994, The Biochemical journal.
[215] R. Ferrante,et al. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[216] Alexander Sasha Rabchevsky,et al. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. , 2001, Journal of neurotrauma.
[217] M. Robin,et al. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells , 2003, The Journal of cell biology.
[218] Y. Wei,et al. Liver mitochondrial respiratory functions decline with age. , 1989, Biochemical and biophysical research communications.
[219] M. Norenberg,et al. Role of oxidative stress in the ammonia-induced mitochondrial permeability transition in cultured astrocytes , 2005, Neurochemistry International.